{
    "abstractText": "Te presence of these indicators undermines our confdence in the integrity of the article\u2019s content and we cannot, therefore, vouch for its reliability. Please note that this notice is intended solely to alert readers that the content of this article is unreliable. We have not investigated whether authors were aware of or involved in the systematic manipulation of the publication process. Wiley and Hindawi regrets that the usual quality checks did not identify these issues before publication and have since put additional measures in place to safeguard research integrity. We wish to credit our own Research Integrity and Research Publishing teams and anonymous and named external researchers and research integrity experts for contributing to this investigation. Te corresponding author, as the representative of all authors, has been given the opportunity to register their agreement or disagreement to this retraction. We have kept a record of any response received.",
    "authors": [],
    "id": "SP:0f0fcc61f4ac302458898c70f065151780f306b6",
    "references": [
        {
            "authors": [
                "S. Vaidya",
                "M.K. Jeengar",
                "M.A. Wadaan"
            ],
            "title": "Design and In Vitro Evaluation of Novel Cationic Lipids for siRNA Delivery in Breast Cancer Cell Lines",
            "venue": "Evidence-Based Complementary and Alternative Medicine, vol. 2022, Article ID 9231641, 9 pages, 2022. Hindawi Evidence-Based Complementary and Alternative Medicine Volume 2023, Article ID 9892315, 1 page https://doi.org/10.1155/2023/9892315",
            "year": 2022
        }
    ],
    "sections": [
        {
            "heading": "Retraction",
            "text": ""
        },
        {
            "heading": "Retracted: Design and In Vitro Evaluation of Novel Cationic",
            "text": ""
        },
        {
            "heading": "Lipids for siRNA Delivery in Breast Cancer Cell Lines",
            "text": ""
        },
        {
            "heading": "Evidence-Based Complementary and Alternative Medicine",
            "text": "Received 1 August 2023; Accepted 1 August 2023; Published 2 August 2023\nCopyright \u00a9 2023 Evidence-Based Complementary and Alternative Medicine.Tis is an open access article distributed under the Creative CommonsAttribution License, which permits unrestricted use, distribution, and reproduction in anymedium, provided the original work is properly cited.\nTis article has been retracted by Hindawi following an investigation undertaken by the publisher [1]. Tis investigation has uncovered evidence of one or more of the following indicators of systematic manipulation of the publication process:\n(1) Discrepancies in scope (2) Discrepancies in the description of the research\nreported (3) Discrepancies between the availability of data and\nthe research described (4) Inappropriate citations (5) Incoherent, meaningless and/or irrelevant content\nincluded in the article (6) Peer-review manipulation\nTe presence of these indicators undermines our confdence in the integrity of the article\u2019s content and we cannot, therefore, vouch for its reliability. Please note that this notice is intended solely to alert readers that the content of this article is unreliable. We have not investigated whether authors were aware of or involved in the systematic manipulation of the publication process.\nWiley and Hindawi regrets that the usual quality checks did not identify these issues before publication and have since put additional measures in place to safeguard research integrity.\nWe wish to credit our own Research Integrity and Research Publishing teams and anonymous and named external researchers and research integrity experts for contributing to this investigation.\nTe corresponding author, as the representative of all authors, has been given the opportunity to register their agreement or disagreement to this retraction. We have kept a record of any response received."
        }
    ],
    "title": "Retraction Retracted: Design and In Vitro Evaluation of Novel Cationic Lipids for siRNA Delivery in Breast Cancer Cell Lines",
    "year": 2023
}